Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00669305 · ClinicalTrials.gov registry record
Bone Marrow for Hemoglobinopathy Research
A clinical trial, sponsored by St. Jude Children's Research Hospital.
- Completed
- Registry status
- 26
- Enrollment target
NCT00669305 is a clinical trial that has completed, run by St. Jude Children's Research Hospital. The registered enrollment target is 26 participants.
The verdict
NCT00669305 has completed, sponsored by St. Jude Children's Research Hospital.
- COMPLETED
- Registry status
- 26 participants
- Enrollment target
Study Summary
Human participants affected with sickle cell disease or thalassemia will donate bone marrow for use in experimental laboratory models to study potential new treatments. This is an observational study using bone marrow from human participants. The investigators will use sickle cell and thalassemia mouse models to observe and evaluate the possibility of correcting these disorders through genetic alterations or drug treatment.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2008-05-15 |
| Est. Completion | 2019-08-29 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00669305
The ClinicalTrials.gov registry entry for NCT00669305 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is St. Jude Children's Research Hospital, which has 410 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00669305 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00669305 about?
NCT00669305 is a clinical study titled "Bone Marrow for Hemoglobinopathy Research". Human participants affected with sickle cell disease or thalassemia will donate bone marrow for use in experimental laboratory models to study potential new treatments. This is an observational study using bone marrow from human participants. The investigators will use sickle cell and thalassemia mo...
What is the current status of trial NCT00669305?
This trial is currently completed. The enrollment target is 26 participants. The study started on 2008-05-15. Estimated completion is 2019-08-29.
Who is sponsoring clinical trial NCT00669305?
This trial is sponsored by St. Jude Children's Research Hospital, which has 410 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.